USANA Health Sciences (USNA) Tops Q4 EPS by 44c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
USANA Health Sciences Inc. (USNA) PT Raised to $126 at Roth Capital
February 10, 2021 7:12 AM ESTRoth Capital analyst David Bain raised the price target on USANA Health Sciences Inc. (NYSE: USNA) to $126.00 (from $107.00) while maintaining a Buy rating.
The analyst comments "Following a 7%/~24% revenue/EBITDA beat versus consensus, we raise our CY21/CY22 estimates and target price.... More

